Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma
Condition(s):Carcinoma, Renal Cell; Clear-cell Metastatic Renal Cell CarcinomaLast Updated:October 6, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Carcinoma, Renal Cell; Clear-cell Metastatic Renal Cell CarcinomaLast Updated:October 6, 2022Completed
Condition(s):Mesothelioma; Peritoneal MesotheliomaLast Updated:January 3, 2024Completed
Condition(s):MelanomaLast Updated:January 26, 2022Active, not recruiting
Condition(s):Metastatic Cancer; Melanoma; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma; Colorectal CancerLast Updated:August 29, 2023Completed
Condition(s):Solid Tumor, Adult; Soft Tissue Sarcoma; Non Small Cell Lung Cancer; Small Cell Lung CancerLast Updated:May 22, 2023Active, not recruiting
Condition(s):GlioblastomaLast Updated:October 11, 2023Unknown status
Condition(s):NonHodgkin Lymphoma; Lymphoproliferative Disorders; EBV Related Lymphoma; EBV-Related PTLD; Hodgkin Lymphoma; EBV Related Non-Hodgkin’s Lymphoma; EBV Related Hodgkin’s LymphomaLast Updated:July 21, 2021Completed
Condition(s):Hodgkin LymphomaLast Updated:January 23, 2020Completed
Condition(s):Breast CancerLast Updated:December 13, 2023Active, not recruiting
Condition(s):Endometrial Adenocarcinoma; Endometrial CarcinosarcomaLast Updated:July 3, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.